RxDoctor Payments Data

Michael Loreti, MD

Sports Medicine · Franklin Lakes, NJNPI 1851384283

Payments from drug & device makers

$3,072in general payments, 2019–2025

Across 151 payments — averaging $20.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$496
  • UCB, Inc.$359
  • Johnson & Johnson$351
  • Kowa Pharmaceuticals America, Inc.$328
  • Fidia Pharma USA Inc.$288
  • Orthofix Medical, Inc.$191
  • plus $1K from 26 others

What the payments were for

  • Food & beverage$3,072100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,072 in reported general payments places this provider in the 65th percentile of 221 sports medicine providers in New Jersey.

See all sports medicine providers in New Jersey

Medicare billing

Part B allowed, 2024
$232,325
Medicare patients
278
Services billed
23,555

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl26$15,434
Oxycodone Hcl351$12,786
EliquisApixaban13$8,501
MovantikNaloxegol Oxalate17$6,741
Ibuprofen-FamotidineIbuprofen/Famotidine22$5,718
Diclofenac Sodium26$5,137
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen171$4,907
Morphine Sulfate ErMorphine Sulfate39$4,258
Lidocaine39$4,139
Celecoxib60$2,580
Nabumetone144$1,636
Tramadol Hcl241$1,351
EndocetOxycodone Hcl/Acetaminophen12$834
Meloxicam259$817
Methylprednisolone103$666

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$50$8,50113 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 221 sports medicine providers in New Jersey.

Other sports medicine in Franklin Lakes

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →